Enlibio，Your biological research partner ！
Xinqidi Biotech Co.,Ltd,Wuhan,China 2008-2022
R&D 14th year
| Blocking glycine utilization inhibits multiple myeloma progression by disrupting glutathione balance | [ Biological abstract ] | 2022-07-15 |
| Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays | [ Biological abstract ] | 2022-07-15 |
| Precision cancer sono-immunotherapy using deep-tissue activatable semiconducting polymer immunomodul | [ Biological abstract ] | 2022-07-15 |
| A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line tr | [ Biological abstract ] | 2022-07-15 |
| MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma | [ Biological abstract ] | 2022-07-01 |
| Network-based machine learning approach to predict immunotherapy response in cancer patients | [ Biological abstract ] | 2022-07-01 |
| Inactivation of the Hippo tumor suppressor pathway promotes melanoma | [ Biological abstract ] | 2022-07-01 |
| Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors | [ Biological abstract ] | 2022-07-01 |
|
|
